Stephen C Olson

Medical School - Twin Cities Campus, Psychiatry

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network

Stephen C Olson

• Organizations
  Medical School - Twin Cities Campus
  
  Psychiatry
  
  

  Current Appointments:

  Associate Professor

  
  
  

612/273-9763

Help us refine your profile

Manage your Funding

23 Grants

This is a chronological listing of grants held by this researcher, with the most recent listed first. This list contains only grants that were active as of July 1, 2008, or awarded since that date. New grants appear in this list periodically and contribute to the researcher's fingerprint profile. The source of grants for this application comes directly from your institution.

• 1.

  Stephen Olson

  A Multicenter, Open-label Study to Assess Hospitalization Rates in Adult Subjects with Schizophrenia Treated Prospectively for 6 Months with Aripiprazole IM Depot Compared with 6-month Retrospective Treatment with Oral Antipsychotics in a Naturalistic Co

  1/2/2012 - 6/30/2014

  Sponsor: Covance Inc.

• 2.

  Angus MacDonald; Stephen Olson

  Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients with Schizophrenia_x000D_ Stablized on Lurasidone

  3/23/2011 - 6/30/2012

  Sponsor: Research Foundation for Mental Hygiene

• 3.

  Stephen Olson; Marc Mooney; Michael O'Sullivan

  A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy_x000D_ of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia(CDS)

  11/1/2010 - 10/30/2011

  Sponsor: Abbott Laboratories

• 4.

  Sellmann Schulz; John Grabowski; Sanjiv Kumra; Kelvin Lim; Marc Mooney; Michael O'Sullivan; Stephen Olson

  Proteomic Diagnostic Test for Schizophrenia

  8/1/2010 - 8/31/2013

  Sponsor: Rules-Based Medicine, Inc

• 5.

  S Fatemi; Dorothy Hatsukami; Stephen Olson

  Varenicline and Smoking Cessation in Schizophrenia

  8/1/2009 - 7/31/2012

  Sponsor: NIH NIDA NATL INST ON DRUG AB

• 6.

  Stephen Olson; Peter Milev

  AstraZeneca D3450-HALO Study

  9/1/2007 - 9/30/2009

  Sponsor: AstraZeneca

• 7.

  Stephen Olson

  A Randomized, Multicenter, Double-blind, Parallel Group Study to Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

  6/29/2007 - 6/30/2009

  Sponsor: SOLVAY PHARM

• 8.

  Stephen Olson

  Sanofi-Aventis DR16726 Cognitive Impairment in Schizophrenia

  4/11/2007 - 12/5/2009

  Sponsor: Sanofi-Aventis US

• 9.

  Stephen Olson

  Validation of the Reasons for Antipsychotic Discontinuation/Continuation Questionnaire (RAD-Q) and Interview (RAD-I)

  2/22/2007 - 12/31/2008

  Sponsor: United BioSource Corporation

• 10.

  Stephen Olson

  A Multi-Center, Open-Label, Parallel-Group, Randomized, Flexible Dose Study to Evaluate the Safety and Tolerability of Switching From Existing Atypical...

  12/22/2006 - 4/30/2008

  Sponsor: SOLVAY PHARM

• 11.

  Stephen Olson

  CAMP - Clinical Assessment of Metabolic Problems

  12/6/2006 - 6/30/2010

  Sponsor: The Univ. of N. Carolina at Chapel Hill

• 12.

  Stephen Olson

  CAMP - Clinical Assessment of Metabolic Problems

  12/6/2006 - 12/5/2008

  Sponsor: The Univ. of N. Carolina at Chapel Hill

• 13.

  Stephen Olson

  A Randomized, Parallel Group, Multiple Dose, 6-week Study to Evalute Safety, Tolerability, and Pharmacokinetics of Asenapine in Elderly Subjects with Psychosis.

  8/21/2006 - 10/31/2008

  Sponsor: ORGANON PHARM INC

• 14.

  Stephen Olson

  Effectiveness of Switching Antipsychotic Medications

  4/26/2006 - 4/30/2009

  Sponsor: The Univ. of N. Carolina at Chapel Hill

• 15.

  Stephen Olson

  Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the Safety & Efficacy of Asenapine w/ Olanzapine in Subjects who Completed Protocl A7501013

  3/27/2006 - 1/7/2008

  Sponsor: QUINTILES INC

• 16.

  Stephen Olson

  Multicenter, Double-Blind, Flexible-Dose, 6-Month Trial Comparing the Efficacy and Safety of Asenapine with Olanzapine in Stable Subjects w/ Predominant, Persistent

  3/27/2006 - 1/7/2008

  Sponsor: QUINTILES INC

• 17.

  Stephen Olson

  A randomized, placebo-controlled, double-blind trial of Asenapine in the prevention of relapse after long-term treatment of Schizophrenia

  2/7/2006 - 9/30/2008

  Sponsor: QUINTILES INC

• 18.

  Stephen Olson

  Efficacy and Safety of Bifeprunox in the Treatment of Schizophrenia - Extension

  9/16/2004 - 12/30/2008

  Sponsor: QUINTILES INC

• 19.

  Stephen Olson

  Efficacy and Safety of Bifeprunox in the Treatment of Schizophrenia - Extension

  9/16/2004 - 7/30/2006

  Sponsor: QUINTILES INC

• 20.

  Stephen Olson

  Efficacy and Safety of Bifeprunox in the Treatment of Schizophrenia

  9/16/2004 - 3/15/2006

  Sponsor: QUINTILES INC

• 21.

  Stephen Olson

  A multicenter, open-label, flexible-dose, parallel-group evaluation of the cataractogenic potential of quetiapine fumarate (Seroquel) and risperidone (Risperdal)

  12/1/2003 - 12/31/2008

  Sponsor: AstraZeneca

• 22.

  Stephen Olson

  Effectiveness of Antipsychotic Medications (Clinical Antipsychotic Trials/Intervention Effectiveness)

  2/18/2002 - 3/31/2010

  Sponsor: The Univ. of N. Carolina at Chapel Hill

• 23.

  Kelvin Lim; Stephen Olson; Jeffrey Wozniak

  White Matter Abnormalities in Schizophrenia

  12/1/1999 - 11/30/2012

  Sponsor: NIH Nat'l Institute of Mental Health